Research location
Santa Cruz de Tenerife
Canary Islands, Spain
Advertisement
Research activity in Santa Cruz de Tenerife
Canary Islands, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 20 trials and 21 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Santa Cruz de Tenerife
20 linked trials · page 1 of 1Association of Assisted Reproductive Technologies Parameters With the Perinatal OutcomeNCT06918236 · 2024-10-01 · 1 site observation
RECRUITING
Oxidative Stress and Cardiovascular Risk in Patients With Rheumatoid ArthritisNCT07760662 · 2024-01-01 · 1 site observation
RECRUITING
Long-term Safety and Efficacy of GBG Study ParticipantsNCT05739591 · 2022-10-12 · 1 site observation
RECRUITING
Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max ForteNCT07427576 · 2025-03-31 · 2 site observations
COMPLETED
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast CancerNCT05592483 · 2023-07-07 · 1 site observation
TERMINATED
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE TrialNCT05569811 · 2022-11-25 · 1 site observation
ACTIVE_NOT_RECRUITING
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic SubtypeNCT05207709 · 2022-03-28 · 1 site observation
TERMINATED
Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast CancerNCT04759248 · 2021-03-15 · 1 site observation
ACTIVE_NOT_RECRUITING
A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 ExpressionNCT04610528 · 2020-12-22 · 1 site observation
UNKNOWN
Registry Study of Pregnancy and Breast CancerNCT04603820 · 2019-11-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerNCT03778931 · 2019-05-10 · 1 site observation
COMPLETED
Observational Study of Obstructive Lung Disease (NOVELTY)NCT02760329 · 2016-07-25 · 1 site observation
COMPLETED
Efficacy and Safety Study of Ozanimod in Relapsing Multiple SclerosisNCT02047734 · 2013-12-03 · 1 site observation
COMPLETED
Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesNCT01618370 · 2012-07-22 · 1 site observation
COMPLETED
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's DiseaseNCT01561053 · 2012-04-19 · 1 site observation
COMPLETED
Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary DiseaseNCT01599871 · 2011-01-01 · 1 site observation
COMPLETED
Chronic Obstructive Pulmonary Disease (COPD) History Assessment In SpaiN (CHAIN)NCT01122758 · 2009-12-01 · 1 site observation
UNKNOWN
Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-RegimensNCT00994344 · 2009-10-01 · 1 site observation
COMPLETED
Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues OnlyNCT00415090 · 2004-08-01 · 1 site observation
COMPLETED
Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV PatientsNCT00318123 · 2004-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.